Markus Maeurer

Markus Maeurer is a Principal Investigator at the Champalimaud Foundation in Lisbon, Portugal, and a clinician-researcher at the University of Mainz, Germany. His work bridges Clinical Immunology, Infectious Diseases, and Cancer Immunotherapy, focusing on tumor-host interactions, mutational burden mapping, and host-directed therapies (HDT) using molecular methods and imaging.

As part of the Against-Cancer-And-Infection consortium, he advances cross-disciplinary collaborations in immuno-oncology and infectious disease research. His lab investigates neoepitopes, trained immunity, and cellular therapies for solid malignancies, tuberculosis, and SARS-CoV-2.

His recent publications (2018–2022) highlight host-pathogen interactions, immune profiling in severe diseases, and MSC-based interventions for infectious and oncological conditions. Key trends include precision medicine, lymphocyte dynamics, and vaccine development for tuberculosis and coronaviruses.

Scientific Awards:

• Vision Award (Champalimaud Foundation)

Students & Collaborators:

• Masters Students: Jéssica Kamiki, Matilde Sedas, Patrícia António
• Postdoctoral Researchers: Carolina Gorgulho, Joana Lérias, Miguel Chaves Ferreira
• Senior Scientist: Mariia Mitina
• Bioinformatician: Eric de Sousa
• Pharmacist: Bernardo Marinheiro